SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.

Candida krusei is increasingly recognized as an opportunistic pathogen in immunocompromised patients and is inherently resistant to fluconazole. We tested the in vivo efficacy of SCH 51048, an investigational antifungal triazole, in experimental hematogenous murine infection caused by two C. krusei...

Fuld beskrivelse

Bibliografiske detaljer

Udgivet i:	Antimicrob Agents Chemother
Principais autores:	Karyotakis, N C, Dignani, M C, Anaissie, E J
Format:	Artigo
Sprog:	Inglês
Udgivet:	American Society for Microbiology (ASM) 1995
Fag:	Research Article
Online adgang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162625/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7793892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.39.3.775
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!